These results collectively show that pathogenicity within PTEN may occur as a spectrum, consistent with the hypothesis proposed by Mighell et al.[12], with the most intense pathogenic mutations leading to cancer, and ASD causing mutations lying between the two extremes (cancer and non-pathogenic). Here, PTEN is linked to cancer.